Pearce Catherine's Form 4 filing
CinCor Pharma, Inc. (CINC) · filed Jan 13, 2022
- Accession no.
- 0001209191-22-003190
- Filed
- Jan 13, 2022
- Trade date
- Jan 11, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $36.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pearce CatherineCIK 0001898815 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 11, 2022 | Common Stock | PPurchaseAcquired | +750 | $16.00 | +$12,000 | 130,911 | Direct | |
| Jan 11, 2022 | Common Stock | PPurchaseAcquired | +1,500 | $16.00 | +$24,000 | 1,500 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.